価格表

在庫・価格 : 2025年10月08日 07時41分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Mouse VEGF R2/Flk-1 MAb (Clone 91202)
データシート※最新のデータシートでない場合があります
MAB4431-500 RSDアールアンドディー システムズ
R&D Systems, Inc.
500 μg ¥237,000
(未発注)
追加

在庫・価格 : 2025年10月08日 07時41分 現在

Anti-Mouse VEGF R2/Flk-1 MAb (Clone 91202)

  • 商品コード:MAB4431-500
  • メーカー:RSD
  • 包装:500μg
  • 価格: ¥237,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Rossato FA et al. Fibrotic Changes and Endothelial-to-Mesenchymal Transition Promoted by VEGFR2 Antagonism Alter the Therapeutic Effects of VEGFA Pathway Blockage in a Mouse Model of Choroidal Neovascularization. Cells 2020 09;9(9)
Rossato FA et al
2020/01/01
Species: Mouse, Applications: Neutralization PubMed
2 Nagai N et al. Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction. Invest. Ophthalmol. Vis. Sci. 2014 Jun;55(6):3709-19
Nagai N et al
2014/01/01
Species: Mouse, Applications: Neutralization PubMed
3 Voron T et al. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J. Exp. Med. 2015 Feb;212(2):139-48
Voron T et al
2015/01/01
Species: Mouse, Applications: Neutralization PubMed
4 Zhang Z et al. alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 2008 Feb;111(4):1980-8
Zhang Z et al
2008/01/01
Species: Mouse, Applications: Western Blot PubMed
5 Polena H et al. Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination. Sci Rep 2016 Sep;6:33162
Polena H et al
2016/01/01
Species: Mouse, Applications: Neutralization PubMed
  • No.: 1
  • 文献情報:
    Rossato FA et al. Fibrotic Changes and Endothelial-to-Mesenchymal Transition Promoted by VEGFR2 Antagonism Alter the Therapeutic Effects of VEGFA Pathway Blockage in a Mouse Model of Choroidal Neovascularization. Cells 2020 09;9(9)
    Rossato FA et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Nagai N et al. Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction. Invest. Ophthalmol. Vis. Sci. 2014 Jun;55(6):3709-19
    Nagai N et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Voron T et al. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J. Exp. Med. 2015 Feb;212(2):139-48
    Voron T et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Zhang Z et al. alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 2008 Feb;111(4):1980-8
    Zhang Z et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Polena H et al. Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination. Sci Rep 2016 Sep;6:33162
    Polena H et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed